Explore
National Library of Medicine

National Library of Medicine

Archive-It Partner Since: Mar, 2009

Organization Type: National Institutions

Organization URL: http://www.nlm.nih.gov/

Description:

The National Library of Medicine (NLM), the world's largest medical library and a component of the National Institutes of Health, collects, preserves, and makes available to the public information about health, medicine, and the biomedical sciences. To continue fulfilling this mission, NLM is collecting and archiving related Web content, which also serves to document the histories of health and medicine. For questions about our web archiving program contact us at nlmwebcollecting@nlm.nih.gov.

Sites and collections from this organization are listed below. Narrow your results at left, or enter a search query below to find a collection, site, specific URL or to search the text of archived webpages.

Page 1 of 1 (12 Total Results)

Sort By:

Title: Press Releases | Moderna, Inc.

URL: https://investors.modernatx.com/news-releases/

Collection: Global Health Events web archive

Description: Website from Moderna about news regarding COVID-19 and the announcement of interim Phase One data for MRNA vaccine.

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Moderna, Inc.

Language: English

Type: Website

Collector: National Library of Medicine (U.S.)

Keyword: Prevention and Control/Risk Management, Vaccines

Title: Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study | Moderna, Inc.

URL: https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy/

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Moderna, Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Biomedical Research, Vaccines

Title: Moderna Receives FDA Advisory Committee Vote Supporting Emergency Use for Moderna’s Vaccine Against COVID-19 in the United States | Moderna, Inc.

URL: https://investors.modernatx.com/news-releases/news-release-details/moderna-receives-fda-advisory-committee-vote-supporting

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Moderna, Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Prevention and Control/Risk Management, Vaccines

Title: Moderna Provides a Clinical Update on the Neutralizing Activity of its COVID-19 Vaccine on Emerging Variants Including the Delta Variant First Identified in India | Moderna, Inc.

URL: https://investors.modernatx.com/news-releases/news-release-details/moderna-provides-clinical-update-neutralizing-activity-its-covid

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Moderna, Inc.

Language: English

Type: Press release

Geographic Location: India

Collector: National Library of Medicine (U.S.)

Keyword: Vaccines, Biomedical Research, Variants, Delta, Tracking the Disease

Title: Moderna Provides COVID-19 Vaccine Supply Update | Moderna, Inc.

URL: https://investors.modernatx.com/news-releases/news-release-details/moderna-provides-covid-19-vaccine-supply-update

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Moderna, Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Prevention and Control/Risk Management, Vaccines

Title: Moderna Announces the European Commission’s Approval of Advance Purchase Agreement for Initial 80 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273) | Moderna, Inc.

URL: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-european-commissions-approval-advance-purchase

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Moderna, Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Vaccines, Prevention and Control/Risk Management

Title: Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus | Moderna, Inc.

URL: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-positive-interim-phase-1-data-its-mrna-vaccine/

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Moderna, Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Biomedical Research, Vaccines

Title: Moderna Announces Longer Shelf Life for its COVID-19 Vaccine Candidate at Refrigerated Temperatures | Moderna, Inc.

URL: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-longer-shelf-life-its-covid-19-vaccine/

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Moderna, Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Biomedical Research, Vaccines

Title: Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Pediatric Population | Moderna, Inc.

URL: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-first-participants-dosed-phase-23-study-0

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Moderna, Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Biomedical Research, Vaccines

Title: Moderna - Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine Spikevax

URL: https://investors.modernatx.com/news/news-details/2022/Moderna-Receives-Full-U.S.-FDA-Approval-for-COVID-19-Vaccine-Spikevax/default.aspx

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Moderna, Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Prevention and Control/Risk Management, Vaccines

Title: Moderna - Moderna Announces Preliminary Booster Data and Updates Strategy to Address Omicron Variant

URL: https://investors.modernatx.com/news/news-details/2021/Moderna-Announces-Preliminary-Booster-Data-and-Updates-Strategy-to-Address-Omicron-Variant/default.aspx

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Moderna, Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Variants, Omicron, Vaccines, Biomedical Research

Title: Moderna - Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Booster Candidate and Publication of Data on Booster Durability Against Omicron Variant

URL: https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-First-Participant-Dosed-in-Phase-2-Study-of-Omicron-Specific-Booster-Candidate-and-Publication-of-Data-on-Booster-Durability-Against-Omicron-Variant/default.aspx

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Group: Coronavirus disease (COVID-19) outbreak

Creator: Moderna, Inc.

Language: English

Type: Press release

Collector: National Library of Medicine (U.S.)

Keyword: Biomedical Research, Vaccines, Patient Treatment and Experience, Variants, Omicron

Page 1 of 1 (12 Total Results)

Archive-It

The leading web archiving service for collecting and accessing cultural heritage on the web

National Library of Medicine

Narrow Your Results

Title: Press Releases | Moderna, Inc.

URL: https://investors.modernatx.com/news-releases/

Title: Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study | Moderna, Inc.

URL: https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy/

Title: Moderna Receives FDA Advisory Committee Vote Supporting Emergency Use for Moderna’s Vaccine Against COVID-19 in the United States | Moderna, Inc.

URL: https://investors.modernatx.com/news-releases/news-release-details/moderna-receives-fda-advisory-committee-vote-supporting

Title: Moderna Provides a Clinical Update on the Neutralizing Activity of its COVID-19 Vaccine on Emerging Variants Including the Delta Variant First Identified in India | Moderna, Inc.

URL: https://investors.modernatx.com/news-releases/news-release-details/moderna-provides-clinical-update-neutralizing-activity-its-covid

Title: Moderna Provides COVID-19 Vaccine Supply Update | Moderna, Inc.

URL: https://investors.modernatx.com/news-releases/news-release-details/moderna-provides-covid-19-vaccine-supply-update

Title: Moderna Announces the European Commission’s Approval of Advance Purchase Agreement for Initial 80 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273) | Moderna, Inc.

URL: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-european-commissions-approval-advance-purchase

Title: Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus | Moderna, Inc.

URL: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-positive-interim-phase-1-data-its-mrna-vaccine/

Title: Moderna Announces Longer Shelf Life for its COVID-19 Vaccine Candidate at Refrigerated Temperatures | Moderna, Inc.

URL: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-longer-shelf-life-its-covid-19-vaccine/

Title: Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Pediatric Population | Moderna, Inc.

URL: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-first-participants-dosed-phase-23-study-0

Title: Moderna - Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine Spikevax

URL: https://investors.modernatx.com/news/news-details/2022/Moderna-Receives-Full-U.S.-FDA-Approval-for-COVID-19-Vaccine-Spikevax/default.aspx

Title: Moderna - Moderna Announces Preliminary Booster Data and Updates Strategy to Address Omicron Variant

URL: https://investors.modernatx.com/news/news-details/2021/Moderna-Announces-Preliminary-Booster-Data-and-Updates-Strategy-to-Address-Omicron-Variant/default.aspx

Title: Moderna - Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Booster Candidate and Publication of Data on Booster Durability Against Omicron Variant

URL: https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-First-Participant-Dosed-in-Phase-2-Study-of-Omicron-Specific-Booster-Candidate-and-Publication-of-Data-on-Booster-Durability-Against-Omicron-Variant/default.aspx

Archive-It